Novel Coronavirus (SARS-CoV-2/COVID-19)
Statement on CMS guidance on elective procedures from AHA President and CEO Rick Pollack.
As you continue discussions with other congressional leaders and the Administration on the next COVID-19 package, we urge you to continue to prioritize additional support to ensure hospitals and health systems have what they need to protect their patients, communities and caregivers.
We urge the President to prioritize additional support to ensure hospitals and health systems continue to have what they need to protect their patients, communities and caregivers. Many hospitals are in dire circumstances as they face the biggest financial crisis in history.
The Food and Drug Administration encouraged those who have recovered from COVID-19 to donate plasma for the creation of convalescent plasma, an antibody-rich investigational therapy that may help others fight the disease.
The Food and Drug Administration issued guidance expanding the use of telethermographic systems for triage use during the public health crisis.
The Centers for Disease Control and Prevention has collated in one location training materials for health care professionals during the COVID-19 emergency, including webinars, videos and online courses.
The FEMA Healthcare Resilience Task Force has released a COVID-19 Hospital Resource Package, which offers tools to help hospitals prepare for and respond to the pandemic.
The Food and Drug Administration announced that spun synthetic swabs made from materials like polyester can be used for test patients for COVID-19.
The Department of Health and Human Services will partner with more than a dozen biopharmaceutical companies and the European Medicines Agency to prioritize vaccine and drug candidates, streamline clinical trials and coordinate regulatory processes to respond to the pandemic, the National Institutes…
The Centers for Medicare & Medicaid Services has created two new Healthcare Common Procedure Coding System codes (U0003 and U0004) to bill under Medicare Part B for clinical diagnostic laboratory tests that use high-throughput technologies to detect and diagnose the novel coronavirus.